Barriers and facilitators of participation in syphilis vaccine trials: a qualitative analysis to inform trial design and community engagement in the United States
Suzanne Day, Asia Carter, Anna Lloyd, Arlene C Seña, Justin D Radolf, Joseph D Tucker · 2025
Read Barriers and facilitators of participation in syphilis vaccine trials: a qualitative analysis to inform trial design and community engagement in the United States by Suzanne Day, Asia Carter, Anna Lloyd, Arlene C Seña, Justin D Radolf, Joseph D Tucker (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12051577.txt.
Description
Day and co-authors interview people in North Carolina who might one day join trials of a future syphilis vaccine. Syphilis rates are climbing again, and a vaccine is in development, but early trials need volunteers from the groups most affected by the infection.
Thirty people were interviewed, including many living with HIV. Most said they would join a trial, though a third said it depended on the details. Fears about physical risks, time demands, and mistrust rooted in past abuses, above all the Tuskegee study, held some back. Trust in the research team and the wish to advance science pulled the other way. The authors urge deep community involvement before trials begin.
Catalog record
| CREATOR | Suzanne Day, Asia Carter, Anna Lloyd, Arlene C Seña, Justin D Radolf, Joseph D Tucker |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |